Women in poor and low-income countries face barriers to gaining access to reliable healthcare, affordable patented drugs, and life-saving essential drugs. In particular, vulnerable and marginalized women in low-income countries suffer the most because of a lack of access to healthcare… Continue reading
The project titled Consolidating Capacities and Conversations on Access to Medicines took forward Sama’s work on access to medicines, with the aim of examining the new drugs which have undergone clinical trials in India and have been approved by the… Continue reading
Sarojini Nadimpally, Divya Bhagianadh | PICR | 2017 The paper discusses the perspectives of clinical trial participants about the various aspects of Clinical Trials (CTs) and is based on the primary research conducted by Sama in 2012-13. The paper describes the… Continue reading
This is a detailed report on the proceedings of a national seminar on issues surrounding new and combination vaccines titled: “New Vaccines for All: Why, Which, When?” that was organised by Sama on October 20-21, 2016, in New Delhi. Continue reading
This is the report of Sama’s study of 2015-2016, which undertook a comparative analysis of compensation mechanisms for clinical trial-related injuries or deaths for seven countries – Brazil, Canada, Germany, India, Russia, South Africa and United Kingdom. Continue reading
This research report is based on a study conducted by Sama during 2015-2016 to assess the accessibility and affordability of drugs for which clinical trials were conducted on the Indian population. The study tried to explore some key issues surrounding clinical trials conducted in India, namely, the availability of those drugs in India, and if so, whether how affordable are they. Continue reading
